Some good news for a change

Wow I can't really believe exactly how desperate some of the big boys on wall street are to get the price of DNDN down as low as they can. I've never seen false headlines being sent out to the press. I really hope the S.E.C. investigates this. Unreal.

OK - now onto the good news. Many clients at Scottrade and Fidelity called and complained about the article with the false headline ( see yesterday's post) . From reading the buzz over one investorvillage.com it looks like Fidelity investigated the incident and REMOVED the fake alert from their web pages. So if this is indeed true - kudos to Fidelity. Scottrade has yet to do so.

And after a long span of negative press The Motley Fool released a more fair and balance article about Dendreon and Provenge. Here is an excerpt. . .

Rocket science?
So what's so great about Dendreon anyway? It's not like it's curing cancer. ... Oh, wait, yes it is.

It would be tough to have missed the small but soaring Dendreon as it has painted the skies in recent weeks. On March 29, Dendreon issued a press release saying that the FDA's Office of Cellular, Tissue, and Gene Therapies Advisory Committee had recommended to the FDA that there is significant evidence of safety and efficacy for Dendreon's prostate cancer drug, Provenge. Provenge is exciting because it would be treating the most prevalent form of cancer after skin cancer -- some reports have put the potential market opportunity at more than $1 billion.

To read more click on the link below. http://www.fool.com/investing/general/2007/04/17/the-5-sigma-report.aspx



More good news . . . Dendreon has new job listings on their website. Interesting to note that one of the positions is for a technology transfer manager. The first duty listed for the Tech Transfer job is " Create the tech transfer procedures at the site that are aligned with Dendreon’s global policies".

So what exactly is technology transfer manager? Don't worry , because I had no idea either.
Here is one definition that a poster on the investorvillage board gave.

Technology Transfer in the high-tech industry means to educate an overseas partner on ways to reproduce a company's product overseas for the local market. It includes patents, confidentiality, legal agreements, localization, etc. for a complete tech.

Seems like things are looking very bright for Dendreon right now - despite what the desperate shorts are trying to spin in the media.


Speaking of jobs , I just can't help but post this information I found out about Brean Murray's Jonathan Aschoff ( the man who has been the loudest in anti Provengecamp) After the whole debacle where he impersonated a doctor to try to get insider information - he was fired from the firm he was working for! I did not know that he was actually fired.

Jonathan Aschoff, biotech analyst fired by Friedman, Billings, Ramsey Group last week for posing as "Dr. Rosen" in an attempt to get information from Genta ...


I wonder if he's going to be reiterating his sell today? He's been rather quiet.

I am sure the shorts are thinking about more attacks behind the scenes. It ain't over till the fat lady sings. They are not going to be giving up without a fight. So if you are long on DNDN check and double check about the authenticity of any articles. We've already seen one fake headline. It could happen again.


Since the big boys are caught on the wrong side of the tracks - they will be trying to employ psychology of fear on what they call "stupid money" (retail longs). Trying to scare the masses into selling their shares . It looks like their efforts are becoming more desperate and futile with each passing day.